


You must have an account with AABS, be logged in, and be registered as a faculty member to search the faculty database.

Case Study: GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (C): THE FIGHT GOES ON
Title
GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (C): THE FIGHT GOES ON
Author
Yaziji, M ; Lindblom, A
Pages
2
Product Type
Reference #
IMD-3-1498
Teaching Note
Institute
Setting
Year
Keywords
Non-government organisations (NGO's) ; Non-market competition ; Ethics ; Pharmaceutical ; AIDS ; Patents; South Africa; Pharmaceutical; Largest pharmaceutical company in the world, more than 100,000 employees; 2001-2004
Summary/
Abstract
Abstract
This is the third of a four-case series (IMD-3-1496 to IMD-3-1499). The (C) part of the series focuses on the actions GlaxoSmithKline (GSK) had to take after being pressured by the non-government organisations (NGO's). The company had been defeated and it agreed to several licensing agreements and price reductions, but the NGO's are still not satisfied. The topic was also gaining importance in the Western media and the big question now was whether it was starting to become an issue in more developed countries, where the vast majority of GSKs' sales and profits were being made.






